Ointments
Ointment Bases
Petrolatum
Administration, Topical
Mupirocin
Administration, Cutaneous
Rats, Hairless
Tacrolimus
Balsams
Clobetasol
Emollients
Dermatitis, Atopic
Diflunisal
Sebum
Bacitracin
Betamethasone
Heparinoids
Facial Dermatoses
Analysis of Chinese herbal creams prescribed for dermatological conditions. (1/387)
OBJECTIVE: To determine whether Chinese herbal creams used for the treatment of dermatological conditions contain steroids. DESIGN: 11 herbal creams obtained from patients attending general and paediatric dermatology outpatient clinics were analysed with high resolution gas chromatography and mass spectrometry. SETTING: Departments of dermatology and clinical biochemistry. MAIN OUTCOME MEASURE: Presence of steroid. RESULTS: Eight creams contained dexamethasone at a mean concentration of 456 micrograms/g (range 64 to 1500 micrograms/g). All were applied to areas of sensitive skin such as face and flexures. CONCLUSION: Greater regulation needs to be imposed on Chinese herbalists to prevent illegal and inappropriate prescribing of potent steroids. (+info)Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. (2/387)
In this randomized, double-blind study, we have compared the ability of 5% liposome-encapsulated tetracaine (amethocaine) (LET) vs 5% eutectic mixture of local anaesthetics (EMLA) to produce local anaesthesia of intact skin in 40 healthy volunteers. Volunteers had both preparations applied to their forearms under an occlusive dressing for 1 h. Superficial anaesthesia was measured by a total of nine 1-mm pinpricks on each arm. Deeper anaesthesia was assessed by single insertion of a sterile 22-gauge needle to a depth of 3 mm and pain was reported on a visual analogue scale (VAS). If the volunteer perceived greater than four of the 1-mm pinpricks, the 3-mm insertion was not performed. Results showed that the number of pinpricks perceived was significantly less (P < 0.01) for LET (median 1.0; range 0-9) vs EMLA (1.5; 0-9). In volunteers who had deeper anaesthesia assessed, there was no significant difference (P = 0.065) in VAS scores for LET (mean 1.5 (SD 1.4); n = 34) vs EMLA (2.4 (2.1); n = 28). Overall anaesthetic effect, as ranked by all of the subjects, was significantly better for LET compared with EMLA (P = 0.024). We have demonstrated that when applied in equal volumes, 5% LET produced better superficial local anaesthesia than EMLA. (+info)Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. (3/387)
The prevalence of onychomycosis, a superficial fungal infection that destroys the entire nail unit, is rising, with no satisfactory cure. The objective of this randomized, double-blind, placebo-controlled study was to examine the clinical efficacy and tolerability of 2% butenafine hydrochloride and 5% Melaleuca alternifolia oil incorporated in a cream to manage toenail onychomycosis in a cohort. Sixty outpatients (39 M, 21 F) aged 18-80 years (mean 29.6) with 6-36 months duration of disease were randomized to two groups (40 and 20), active and placebo. After 16 weeks, 80% of patients using medicated cream were cured, as opposed to none in the placebo group. Four patients in the active treatment group experienced subjective mild inflammation without discontinuing treatment. During follow-up, no relapse occurred in cured patients and no improvement was seen in medication-resistant and placebo participants. (+info)New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. (4/387)
AIM: To demonstrate the efficacy of a petrolatum based calcium ointment applied to the lower lid skin in the management of dry eye. METHODS: In a controlled double masked study, the effects of water free petrolatum ointment containing calcium carbonate (10% w/w) on tear functional factors and ocular surface vital staining in dry eye patients were observed. Petrolatum without calcium carbonate served as control. Patients were instructed to place ointment to the lower lid skin twice a day. Evaluation of subjective complaints, fluorescein and rose bengal staining patterns, blink rate, tear evaporation and tear break up time (BUT) were performed before and 3 months after treatment. In order to demonstrate the movement of petrolatum from the skin to the tear film, petrolatum containing 1% sodium fluorescein was placed on the lower lid of four healthy volunteers, and the concentration of fluorescein in the tear film was followed up to 6 hours using an anterior fluorometer. RESULTS: Subjective symptoms significantly improved in both the calcium group (p=0.001) and control (p=0.012), while only the calcium group demonstrated a significant improvement in fluorescein (p=0.043), rose bengal (p=0.021) scores, and blink rate (p=0.004). Tear evaporation also significantly decreased in both the calcium group (p=0.0004) and control (0.043). BUT did not improve in either group. CONCLUSION: Petrolatum based calcium ointment significantly improved symptoms, tear dynamics, and ocular surface staining in dry eye patients. However, some of the therapeutic effects may be due to lipids in the petrolatum vehicle. Petrolatum applied to the lower lid skin is an effective drug delivery system for slowly releasing drugs to the ocular surface. (+info)A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. (5/387)
BACKGROUND AND METHODS: Lateral internal sphincterotomy, the most common treatment for chronic anal fissure, may cause permanent injury to the anal sphincter, which can lead to fecal incontinence. We compared two nonsurgical treatments that avert the risk of fecal incontinence. We randomly assigned 50 adults with symptomatic chronic posterior anal fissures to receive treatment with either a total of 20 U of botulinum toxin injected into the internal anal sphincter on each side of the anterior midline or 0.2 percent nitroglycerin ointment applied twice daily for six weeks. RESULTS: After two months, the fissures were healed in 24 of the 25 patients (96 percent) in the botulinum-toxin group and in 15 of the 25 (60 percent) in the nitroglycerin group (P=0.005). No patient in either group had fecal incontinence. At some time during treatment, five patients in the nitroglycerin group had transient, moderate-to-severe headaches that were related to treatment. None of the patients in the botulinum-toxin group reported adverse effects. Ten patients who did not have a response to the assigned treatment - 1 in the botulinum-toxin group and 9 in the nitroglycerin group - crossed over to the other treatment; the fissures subsequently healed in all 10 patients. There were no relapses during an average of about 15 months of follow-up. CONCLUSIONS: Although treatment with either topical nitroglycerin or botulinum toxin is effective as an alternative to surgery for patients with chronic anal fissure, botulinum toxin is the more effective nonsurgical treatment. (+info)A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. (6/387)
Seventy-six human immunodeficiency virus (HIV)-infected patients with Staphylococcus aureus nasal carriage were randomized to treatment groups receiving intranasal mupirocin or placebo twice daily for 5 days. Nasal cultures for S. aureus were obtained at 1, 2, 6, and 10 weeks after therapy. At 1 week, 88% of mupirocin-treated patients had negative nasal cultures compared with 8% in placebo patients (P<.001). The percentage of mupirocin-treated patients with persistently negative nasal cultures decreased over time (63%, 45%, and 29% at 2, 6, and 10 weeks, respectively) but remained significantly greater than the placebo group (3% at 2, 6, and 10 weeks). In mupirocin-treated patients, most (16/19) instances of nasal recolonization were with pretreatment strains (determined by means of by pulsed field gel electrophoresis); mupirocin resistance was not observed. Five days of treatment with mupirocin eliminated S. aureus nasal carriage in HIV-infected patients for several weeks; however, since the effect waned over time, intermittent dosing regimens should be considered for long-term eradication. (+info)Tetracaine gel vs EMLA cream for percutaneous anaesthesia in children. (7/387)
We have evaluated the anaesthetic effect of tetracaine gel 1 g, applied for 45 min, compared with EMLA cream 2 g, applied for 60 min, in a randomized, double-blind study in 60 children aged 3-15 yr. Venous cannulation was performed 15 min after removal of the EMLA cream (n = 20) and tetracaine gel (n = 20). Cannulation was performed up to 215 min after removal of the tetracaine gel in another 20 patients. Significantly lower pain scores were recorded by the children treated with tetracaine gel compared with EMLA cream (P < 0.02). Forty to 45% of children in the tetracaine groups reported no pain compared with only 10% in the EMLA group. Only minor adverse effects were observed. We conclude that tetracaine gel provided effective, rapid, long-lasting and safe local anaesthesia, and was significantly better than EMLA cream in reducing pain during venous cannulation in children using the recommended application periods for both formulations. (+info)Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection. (8/387)
The topical efficacies of foscarnet and acyclovir incorporated into a polyoxypropylene-polyoxyethylene polymer were evaluated and compared to that of 5% acyclovir ointment (Zovirax) by use of a murine model of cutaneous herpes simplex virus type 1 infection. All three treatments given three times daily for 4 days and initiated 24 h after infection prevented the development of the zosteriform rash in mice. The acyclovir formulation and the acyclovir ointment reduced the virus titers below detectable levels in skin samples from the majority of mice, whereas the foscarnet formulation has less of an antiviral effect. Reducing the number of treatments to a single application given 24 h postinfection resulted in a significantly higher efficacy of the formulation of acyclovir than of the acyclovir ointment. Acyclovir incorporated within the polymer was also significantly more effective than the acyclovir ointment when treatment was initiated on day 5 postinfection. The higher efficacy of the acyclovir formulation than of the acyclovir ointment is attributed to the semiviscous character of the polymer, which allows better penetration of the drug into the skin. (+info)An ointment is a semi-solid preparation, typically composed of a mixture of medicinal substance with a base, which is usually greasy or oily. The purpose of the base is to act as a vehicle for the active ingredient and allow it to be applied smoothly and evenly to the skin or mucous membranes.
Ointments are commonly used in dermatology to treat various skin conditions such as eczema, psoriasis, rashes, burns, and wounds. They can also be used to deliver medication for localized pain relief, muscle relaxation, and anti-inflammatory or antibiotic effects.
The base of an ointment may consist of various ingredients, including petrolatum, lanolin, mineral oil, beeswax, or a combination of these. The choice of the base depends on the desired properties such as consistency, spreadability, and stability, as well as the intended route of administration and the specific therapeutic goals.
Ointment bases refer to the vehicle or foundation in which active pharmaceutical ingredients are dispersed to form a semi-solid medication. These bases provide the necessary consistency for ointments, allowing easy application to the skin or other body surfaces. They can be composed of various materials such as fats, waxes, oils, and emulsifying agents.
The choice of an ointment base depends on several factors, including:
1. The desired physical properties (e.g., spreadability, absorption rate)
2. The route of administration (e.g., dermal, mucosal)
3. The compatibility with the active ingredient(s)
4. The intended therapeutic effect (e.g., occlusive, non-occlusive)
Some common types of ointment bases include:
1. Hydrocarbon bases: Consist of hydrophobic materials like petrolatum, white soft paraffin, and microcrystalline wax. They are generally inert, odorless, and resistant to oxidation.
2. Absorption bases: Contain a mixture of hydrocarbons and higher molecular weight esters or fatty alcohols. These bases have better penetrating properties than hydrocarbon bases and are suitable for drugs with low oil solubility.
3. Emulsifying bases: Comprise of water-in-oil (W/O) or oil-in-water (O/W) emulsions, which allow the dispersion of both hydrophilic and lipophilic drugs. Common examples include cetomacrogol and anhydrous lanette.
4. Water-soluble bases: Primarily consist of polyethylene glycols (PEGs) or other water-soluble materials. They are useful for drugs with high water solubility and provide a cooling sensation upon application.
It is essential to select an appropriate ointment base to ensure the optimal delivery, stability, and efficacy of the active ingredient(s).
Petrolatum is a semi-solid mixture of hydrocarbons obtained from petroleum. In the medical field, it's often used as an ointment base or protective dressing because of its impermeability to water and bacteria. It's also known as petroleum jelly or soft paraffin.
Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).
Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.
When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.
Mupirocin is a topical antibiotic medication used to treat infections caused by bacteria. Its medical definition, according to the National Library of Medicine (NLM), is: "A topical antimicrobial agent that is used to eradicate staphylococcal and streptococcal bacteria from the nose and skin. It is also used as a first-line treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections."
Mupirocin works by inhibiting protein synthesis in bacteria, which prevents them from multiplying. This topical antibiotic is available as an ointment or cream and is usually applied three times a day for 5 to 10 days. It is important to note that mupirocin should only be used to treat bacterial infections and not viral or fungal infections, as it has no effect on these types of pathogens.
"Cutaneous administration" is a route of administering medication or treatment through the skin. This can be done through various methods such as:
1. Topical application: This involves applying the medication directly to the skin in the form of creams, ointments, gels, lotions, patches, or solutions. The medication is absorbed into the skin and enters the systemic circulation slowly over a period of time. Topical medications are often used for local effects, such as treating eczema, psoriasis, or fungal infections.
2. Iontophoresis: This method uses a mild electrical current to help a medication penetrate deeper into the skin. A positive charge is applied to a medication with a negative charge, or vice versa, causing it to be attracted through the skin. Iontophoresis is often used for local pain management and treating conditions like hyperhidrosis (excessive sweating).
3. Transdermal delivery systems: These are specialized patches that contain medication within them. The patch is applied to the skin, and as time passes, the medication is released through the skin and into the systemic circulation. This method allows for a steady, controlled release of medication over an extended period. Common examples include nicotine patches for smoking cessation and hormone replacement therapy patches.
Cutaneous administration offers several advantages, such as avoiding first-pass metabolism (which can reduce the effectiveness of oral medications), providing localized treatment, and allowing for self-administration in some cases. However, it may not be suitable for all types of medications or conditions, and potential side effects include skin irritation, allergic reactions, and systemic absorption leading to unwanted systemic effects.
I'm sorry for any confusion, but "Rats, Hairless" is not a recognized medical term or condition. The term "hairless rat" typically refers to a specific breed of domesticated rats, also known as "Smooth-haired Rats" or "Naked Rats," which have a genetic mutation that results in the absence of fur. They are often kept as pets and are used in laboratory research. If you're looking for information on a specific medical condition or term, please provide it, and I would be happy to help.
Skin absorption, also known as percutaneous absorption, refers to the process by which substances are taken up by the skin and pass into the systemic circulation. This occurs when a substance is applied topically to the skin and penetrates through the various layers of the epidermis and dermis until it reaches the capillaries, where it can be transported to other parts of the body.
The rate and extent of skin absorption depend on several factors, including the physicochemical properties of the substance (such as its molecular weight, lipophilicity, and charge), the concentration and formulation of the product, the site of application, and the integrity and condition of the skin.
Skin absorption is an important route of exposure for many chemicals, drugs, and cosmetic ingredients, and it can have both therapeutic and toxicological consequences. Therefore, understanding the mechanisms and factors that influence skin absorption is crucial for assessing the safety and efficacy of topical products and for developing strategies to enhance or reduce their absorption as needed.
Dermatologic agents are medications, chemicals, or other substances that are applied to the skin (dermis) for therapeutic or cosmetic purposes. They can be used to treat various skin conditions such as acne, eczema, psoriasis, fungal infections, and wounds. Dermatologic agents include topical corticosteroids, antibiotics, antifungals, retinoids, benzoyl peroxide, salicylic acid, and many others. They can come in various forms such as creams, ointments, gels, lotions, solutions, and patches. It is important to follow the instructions for use carefully to ensure safety and effectiveness.
Tacrolimus is an immunosuppressant drug that is primarily used to prevent the rejection of transplanted organs. It works by inhibiting the activity of T-cells, which are a type of white blood cell that plays a central role in the body's immune response. By suppressing the activity of these cells, tacrolimus helps to reduce the risk of an immune response being mounted against the transplanted organ.
Tacrolimus is often used in combination with other immunosuppressive drugs, such as corticosteroids and mycophenolate mofetil, to provide a comprehensive approach to preventing organ rejection. It is available in various forms, including capsules, oral solution, and intravenous injection.
The drug was first approved for use in the United States in 1994 and has since become a widely used immunosuppressant in transplant medicine. Tacrolimus is also being studied as a potential treatment for a variety of other conditions, including autoimmune diseases and cancer.
Balsams are a type of resinous substance that is produced by trees and plants. They have been used historically in medicine for their therapeutic properties, particularly as an expectorant and anti-inflammatory agent. Some common balsams used in medicine include:
1. Canada Balsam (Abies balsamea): A resin obtained from the bark of the balsam fir tree, which has been used in medicine for its antiseptic and anti-inflammatory properties. It is also used as a cement or adhesive in microscopy.
2. Tolu Balsam (Myroxylon balsamum): A resin obtained from the bark of the tree Myroxylon balsamum, which is native to Central and South America. It has been used in medicine for its expectorant, antispasmodic, and analgesic properties.
3. Peru Balsam (Myroxylon pereirae): A resin obtained from the tree Myroxylon pereirae, which is native to Central America. It has been used in medicine for its antiseptic, anti-inflammatory, and analgesic properties.
4. Benzoin Balsam (Styrax benzoin): A resin obtained from the tree Styrax benzoin, which is native to Southeast Asia. It has been used in medicine for its expectorant, antiseptic, and anti-inflammatory properties.
It's important to note that balsams can cause skin irritation and allergic reactions in some people, so they should be used with caution and under the guidance of a healthcare professional.
Clobetasol is a topical corticosteroid medication that is used to reduce inflammation and relieve itching, redness, and swelling associated with various skin conditions. It works by suppressing the immune system's response to reduce inflammation. Clobetasol is available in several forms, including creams, ointments, emulsions, and foams, and is usually applied to the affected area once or twice a day.
It is important to use clobetasol only as directed by a healthcare provider, as prolonged or excessive use can lead to thinning of the skin, increased susceptibility to infections, and other side effects. Additionally, it should not be used on large areas of the body or for extended periods without medical supervision.
Emollients are medical substances or preparations used to soften and soothe the skin, making it more supple and flexible. They work by forming a barrier on the surface of the skin that helps to prevent water loss and protect the skin from irritants and allergens. Emollients can be in the form of creams, lotions, ointments, or gels, and are often used to treat dry, scaly, or itchy skin conditions such as eczema, psoriasis, and dermatitis. They may contain ingredients such as petroleum jelly, lanolin, mineral oil, or various plant-derived oils and butters. Emollients can also help to reduce inflammation and promote healing of the skin.
Atopic dermatitis is a chronic, inflammatory skin condition that is commonly known as eczema. It is characterized by dry, itchy, and scaly patches on the skin that can become red, swollen, and cracked over time. The condition often affects the skin on the face, hands, feet, and behind the knees, and it can be triggered or worsened by exposure to certain allergens, irritants, stress, or changes in temperature and humidity. Atopic dermatitis is more common in people with a family history of allergies, such as asthma or hay fever, and it often begins in infancy or early childhood. The exact cause of atopic dermatitis is not fully understood, but it is thought to involve a combination of genetic and environmental factors that affect the immune system and the skin's ability to maintain a healthy barrier function.
Diflunisal is a non-steroidal anti-inflammatory drug (NSAID) that is used to relieve pain, reduce inflammation, and lower fever. It works by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation in the body.
Diflunisal is available in immediate-release and extended-release tablets, and it is typically taken two to four times a day, depending on the severity of symptoms and the dosage prescribed by a healthcare provider. Common side effects of diflunisal include stomach pain, nausea, vomiting, diarrhea, headache, dizziness, and skin rash.
Like other NSAIDs, diflunisal carries a risk of serious side effects, including gastrointestinal bleeding, ulcers, and perforations; kidney damage; and increased risk of heart attack and stroke. It should be used with caution in people with a history of stomach ulcers or bleeding disorders, kidney or liver disease, high blood pressure, or heart disease.
It is important to follow the dosage instructions provided by a healthcare provider and to discuss any potential risks and benefits of taking diflunisal before starting therapy.
Sebum is an oily, waxy substance that is produced by the sebaceous glands in the skin of mammals. It is composed mainly of triglycerides, wax esters, squalene, and free fatty acids, as well as smaller amounts of metabolites and other substances. Sebum plays an important role in the maintenance of the skin's barrier function and in the regulation of its moisture levels. It also has antimicrobial properties that help to protect the skin from infection. Excessive sebum production can contribute to the development of acne and other skin conditions.
Bacitracin is an antibiotic drug that is primarily used topically, in the form of ointments or creams, to prevent and treat skin infections caused by bacteria. It works by inhibiting the bacterial protein synthesis necessary for their growth and multiplication. Bacitracin is not typically used systemically due to its potential nephrotoxicity (kidney toxicity) when given internally.
The medical definition of 'Bacitracin' is:
A polypeptide antibiotic derived from a strain of Bacillus subtilis, with a molecular weight of about 1450 daltons. It is used topically for its antibacterial properties and is often combined with other agents such as neomycin and polymyxin B in ointments or creams to treat skin infections. Bacitracin inhibits bacterial cell wall synthesis by blocking the transfer of amino acids during peptidoglycan formation, thereby exerting a bacteriostatic effect on susceptible organisms. It is not used systemically due to its potential nephrotoxicity.
Betamethasone is a type of corticosteroid medication that is used to treat various medical conditions. It works by reducing inflammation and suppressing the activity of the immune system. Betamethasone is available in several forms, including creams, ointments, lotions, gels, solutions, tablets, and injectable preparations.
The medical definition of betamethasone is:
A synthetic corticosteroid with anti-inflammatory, immunosuppressive, and vasoconstrictive properties. It is used to treat a variety of conditions such as skin disorders, allergies, asthma, arthritis, and autoimmune diseases. Betamethasone is available in various formulations including topical (creams, ointments, lotions, gels), oral (tablets), and injectable preparations. It acts by binding to specific receptors in cells, which leads to the inhibition of the production of inflammatory mediators and the suppression of immune responses.
It is important to note that betamethasone should be used under the guidance of a healthcare professional, as it can have significant side effects if not used properly.
Heparinoids are a group of substances that have similar properties to heparin, a highly sulfated glycosaminoglycan found in mast cells and basophils. Heparin is a powerful anticoagulant that works by accelerating the action of an enzyme called antithrombin III, which inhibits the formation of blood clots.
Heparinoids are often used as alternative anticoagulants to heparin in clinical settings. They have similar mechanisms of action and can also inhibit the coagulation cascade, preventing the formation of blood clots. However, heparinoids have a lower anticoagulant activity than heparin and may have different side effect profiles.
Examples of heparinoids include low molecular weight heparins (LMWHs), fondaparinux, and danaparoid. LMWHs are derived from standard heparin by chemical or enzymatic depolymerization and have a lower molecular weight than heparin. They have a more predictable anticoagulant response and longer half-life than standard heparin, making them useful for outpatient treatment of deep vein thrombosis and pulmonary embolism.
Fondaparinux is a synthetic pentasaccharide that selectively binds to antithrombin III and enhances its inhibitory activity against factor Xa, a key enzyme in the coagulation cascade. It has a long half-life and predictable pharmacokinetics, making it useful for the prevention and treatment of venous thromboembolism.
Danaparoid is a mixture of heparan sulfate, dermatan sulfate, and chondroitin sulfate derived from pig intestinal mucosa. It has a lower anticoagulant activity than heparin but a longer half-life and less frequent dosing requirements. Danaparoid is used for the prevention and treatment of venous thromboembolism, as well as for the management of heparin-induced thrombocytopenia (HIT), a rare but serious complication of heparin therapy.
Facial dermatoses refer to various skin conditions that affect the face. These can include a wide range of disorders, such as:
1. Acne vulgaris: A common skin condition characterized by the formation of comedones (blackheads and whiteheads) and inflammatory papules, pustules, and nodules. It primarily affects the face, neck, chest, and back.
2. Rosacea: A chronic skin condition that causes redness, flushing, and visible blood vessels on the face, along with bumps or pimples and sometimes eye irritation.
3. Seborrheic dermatitis: A common inflammatory skin disorder that causes a red, itchy, and flaky rash, often on the scalp, face, and eyebrows. It can also affect other oily areas of the body, like the sides of the nose and behind the ears.
4. Atopic dermatitis (eczema): A chronic inflammatory skin condition that causes red, itchy, and scaly patches on the skin. While it can occur anywhere on the body, it frequently affects the face, especially in infants and young children.
5. Psoriasis: An autoimmune disorder that results in thick, scaly, silvery, or red patches on the skin. It can affect any part of the body, including the face.
6. Contact dermatitis: A skin reaction caused by direct contact with an allergen or irritant, resulting in redness, itching, and inflammation. The face can be affected when allergens or irritants come into contact with the skin through cosmetics, skincare products, or other substances.
7. Lupus erythematosus: An autoimmune disorder that can cause a butterfly-shaped rash on the cheeks and nose, along with other symptoms like joint pain, fatigue, and photosensitivity.
8. Perioral dermatitis: A inflammatory skin condition that causes redness, small bumps, and dryness around the mouth, often mistaken for acne. It can also affect the skin around the nose and eyes.
9. Vitiligo: An autoimmune disorder that results in the loss of pigmentation in patches of skin, which can occur on the face and other parts of the body.
10. Tinea faciei: A fungal infection that affects the facial skin, causing red, scaly, or itchy patches. It is also known as ringworm of the face.
These are just a few examples of skin conditions that can affect the face. If you experience any unusual symptoms or changes in your skin, it's essential to consult a dermatologist for proper diagnosis and treatment.
Croton oil is a highly toxic, irritant, and vesicant liquid that is derived from the seeds of the croton tiglium plant. It is a type of unsaturated fatty acid known as an octadecatrienoic acid, and it contains a mixture of various chemical compounds including crotonic acid, diglycerides, and phorbol esters.
Croton oil is commonly used in laboratory research as a pharmacological tool to study the mechanisms of inflammation, pain, and skin irritation. It can also be used as a veterinary medicine to treat certain types of intestinal parasites in animals. However, due to its high toxicity and potential for causing severe burns and blisters on the skin, it is not used in human medicine.
It's important to note that croton oil should only be handled by trained professionals in a controlled laboratory setting, as improper use or exposure can result in serious injury or death.